Impact of comorbidities constituting the hematopoietic cell transplant (HCT) ‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia
ConclusionAmong the comorbidities that compose the HCT‐CI, diabetes and cardiovascular comorbidity independently predict NRM in patients undergoing allogeneic HCT for AML. This information should be taken into consideration regarding post‐transplant monitoring and care.
Source: European Journal of Haematology - Category: Hematology Authors: Manar M. I. Khalil, Jeffrey H. Lipton, Eshetu G. Atenafu, Vikas Gupta, Dennis D. Kim, John Kuruvilla, Auro Viswabandya, Hans A. Messner, Fotios V. Michelis Tags: ORIGINAL ARTICLE Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Hematology | Leukemia | Study | Transplants